Irritable Bowel syndrome

Mar 20, 2024

Over the years, the landscape of Digestive Health Products has undergone significant evolution driven by advancements in scientific understanding, changing consumer preferences, and emerging market trends. As per the latest study by DelveInsight, the global Digestive Health Products market was valued at USD 39,345....

Apr 21, 2021

Over the past few decades, the estimated incidence and prevalence of digestive disorders have increased significantly. Some of the factors such as industrialization, changing dietary habits, use of antibiotics, smoking, infection, sanitation, and many others have contributed to this inclining trend. Digestive Di...

Nov 26, 2020

Cancer-killing virus flees immune destruction and attacks metastatic lung tumors in mice Several viruses have a natural ability to eliminate cancer; however translating them into treatments has proven difficult, partly due to the immune system tends to kill them before they can reach cancer cells. Researchers fr...

Sep 18, 2019

Recently the U.S. Food and Drug Administration has recommended the use of Ibsrela (tenapanor), for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. A 50 mg, twice daily oral pill, Ibsrela is a small molecule that acts locally in the gastrointestinal tract to inhibit the sodium-hydrogen...